BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Norris EJ, Zhang Q, Jones WD, DeStephanis D, Sutker AP, Livasy CA, Ganapathi RN, Tait DL, Ganapathi MK. Increased expression of neurotensin in high grade serous ovarian carcinoma with evidence of serous tubal intraepithelial carcinoma. J Pathol 2019;248:352-62. [PMID: 30883751 DOI: 10.1002/path.5264] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Takahashi K, Ehata S, Miyauchi K, Morishita Y, Miyazawa K, Miyazono K. Neurotensin receptor 1 signaling promotes pancreatic cancer progression. Mol Oncol 2021;15:151-66. [PMID: 33034134 DOI: 10.1002/1878-0261.12815] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
2 Al-Alem L, Puttabyatappa M, Shrestha K, Choi Y, Rosewell K, Brännström M, Akin J, Jo M, Duffy DM, Curry TE. Neurotensin: a neuropeptide induced by hCG in the human and rat ovary during the periovulatory period†. Biol Reprod 2021;104:1337-46. [PMID: 33682882 DOI: 10.1093/biolre/ioab036] [Reference Citation Analysis]
3 Ghaemimanesh F, Mehravar M, Milani S, Poursani EM, Saliminejad K. The multifaceted role of sortilin/neurotensin receptor 3 in human cancer development. J Cell Physiol 2021;236:6271-81. [PMID: 33634506 DOI: 10.1002/jcp.30344] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Narayan V, Thompson EW, Demissei B, Ho JE, Januzzi JL Jr, Ky B. Mechanistic Biomarkers Informative of Both Cancer and Cardiovascular Disease: JACC State-of-the-Art Review. J Am Coll Cardiol 2020;75:2726-37. [PMID: 32466889 DOI: 10.1016/j.jacc.2020.03.067] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 13.0] [Reference Citation Analysis]
5 Qiu S, Nikolaou S, Zhu J, Jeffery P, Goldin R, Kinross J, Alexander JL, Rasheed S, Tekkis P, Kontovounisios C. Characterisation of the Expression of Neurotensin and Its Receptors in Human Colorectal Cancer and Its Clinical Implications. Biomolecules 2020;10:E1145. [PMID: 32764278 DOI: 10.3390/biom10081145] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Fanelli R, Chastel A, Previti S, Hindié E, Vimont D, Zanotti-fregonara P, Fernandez P, Garrigue P, Lamare F, Schollhammer R, Balasse L, Guillet B, Rémond E, Morgat C, Cavelier F. Silicon-Containing Neurotensin Analogues as Radiopharmaceuticals for NTS 1 -Positive Tumors Imaging. Bioconjugate Chem 2020;31:2339-49. [DOI: 10.1021/acs.bioconjchem.0c00419] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
7 Ma S, Zheng Y, Fei C. Identification of key factors associated with early- and late-onset ovarian serous cystadenocarcinoma. Future Oncol 2020;16:2821-33. [PMID: 32885674 DOI: 10.2217/fon-2020-0668] [Reference Citation Analysis]